Irish firm Covidien has announced it intends to spin off its Hazelwood, Mo.-based pharmaceutical unit Mallinckrodt on June 28. The spinoff company will be called Mallinckrodt Pharmaceuticals.
Published in Brief:
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan